Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent application · clear
On December 20, 2023, the UK Supreme Court made a significant ruling , stating that artificial intelligence (AI) systems are not eligible to be recognized as inventors in patent applications. This decision aligns with similar judgments from entities like…
As an inventor, it's important to protect your ideas and inventions from being copied or stolen by others. One of the ways to do this is by filing a patent application with the US Patent and Trademark Office (USPTO). However, the process of preparing…
In 2019, Stephen Thaler filed two patent applications, 16/524,350 (teaching a “Neural Flame”) and 16/524,532 (teaching a “Fractal Container”). What was unusual in these applications was that he named an AI system called DABUS…
Last week we highlighted the companies with the largest growth or decline in patents in 2021 ( Patexia 140 ). Covering a period of five years, from January 1st, 2017, through December 31st, 2021, the full Patent Prosecution Intelligence report analyzes the…
Earlier this year, we published our Third Annual Patent Prosecution Intelligence Report. Based on this report, we identified the patent firms with the largest growth or decline in 2020 in Patexia Insight 107 . This was a noteworthy year for both positive…
In my last post, I discussed the Supreme Court’s opinion in Helsinn Healthcare v. Teva Pharms ., holding Helsinn’s patent on a drug was invalid on the basis that Helsinn’s semi-secret sale of the drug to a marketing partner triggered the…
A pair of ongoing USPTO initiatives, Patents for Humanity and Patents 4 Patients, offer incentives that certain biotechnology patent applications may be eligible for. Patents for Humanity is open to patents and applications that address humanitarian…
Written by Peter E. Heuser , Schwabe, Williamson & Wyatt In Nidec v. Zhongshan , the entire panel affirms a determination of obviousness but two judges question whether § 315(c) of the AIA was improperly used to permit joinder as to a second Zhongshan…
Written by Scott Siera, Ph.D. and Michael L. Fuller Obtaining issued patents in the biotechnology space can be a challenge. Here is a list of ten patent strategies we recommend for biotechnology innovators to increase their odds of obtaining valuable…
Written by Hyeongsu Rick Park and Kerry S. Taylor, Ph.D. The Patent Trial and Appeal Board (PTAB) terminated a patent interference proceeding between the University of California (UC) and the Broad Institute (Broad), a joint venture of Harvard University…
An Internet search using the term "provisional patent application" will bury you in ads by companies offering inventors a low-cost entry ticket to the U.S. patent system. I'm concerned, but not surprised. The U.S. provisional patent…
By Christopher Hall & Mike Gencarella Here is an argument we are using in response to rejections under 35 USC §101 that allege the claims are directed to an abstract idea and are patent ineligible. This is useful in Office action responses, and…
